C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07K 16/40 (2006.01) C12N 9/64 (2006.01)
Patent
CA 2271770
Prostate cancer is detected by determining the presence of prostate specific glandular Kallikrein (hK2) polypeptide or hK2 RNA in a physiological sample.
Selon le procédé de la présente invention, on détecte le cancer de la prostate en déterminant la présence d'un polypeptide glandullaire spécifique de la prostate appelé Kallikrein (hK2) ou d'un ARN de hK2 dans un échantillon physiologique.
Klee George G.
Kumar Abhay
Mccormick Daniel J.
Rittenhouse Harry G.
Saedi Mohammad Saeed
Gowling Lafleur Henderson Llp
Hybritech Incorporated
Mayo Foundation For Medical Education And Research
LandOfFree
Method for detection of metastatic prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detection of metastatic prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detection of metastatic prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2084019